FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Cefazolin Better than Vancomycin for Some Blood Infections: Study

[ Price : $8.95]

A new study suggests that cefazolin appears to be better for treating certain bloodstream infections than widely prescribed vancom...

FDA Clears United Healths Hemostyp Gauze

[ Price : $8.95]

FDA clears a United Health Products 510(k) for its hemostatic gauze Hemostyp.

FDA Approves Study for New Avian Flu Vaccine

[ Price : $8.95]

FDA approves an IDE from the Infectious Disease Research Institute and Medicago to initiate a Phase 1 clinical trial for their H5N...

FDA Clears Ormco Orthodontic System

[ Price : $8.95]

FDA clears an Ormco Corp. 510(k) for its Insignia combination 3-D treatment planning software and customized appliances system.

Workshop on Clinical Trials of Drug/Biologics in Kidney Transplants

[ Price : $8.95]

Federal Register Notice: FDA plans a public workshop 9/10-11 on endpoints for clinical trials of drugs and biologics in kidney tra...

Dallas District Co-sponsors Workshop on Clinical Trials

[ Price : $8.95]

Federal Register Notice: FDAs Office of Regulatory Affairs, Dallas District Office and the Society of Clinical Research Associates...

FDA OKs Expanded Use for Pharmalucence Imaging Agent

[ Price : $8.95]

FDA approves a Pharmalucence NDA supplement for sulfur colloid injection (SCI) to expand its use for localization of lymph nodes i...

Clinical Hold on Idenix Investigational Hep C Drug

[ Price : $8.95]

FDA puts a partial clinical hold on development of Idenix IDX184 for treating hepatitis C.

Panel to Discuss Lipid Emulsion Products

[ Price : $8.95]

Federal Register Notice: FDAs Gastrointestinal Drugs Advisory Committee will meet 10/15 to discuss clinical development programs t...

Panel to Discuss Genzyme NDA to Treat High Cholesterol

[ Price : $8.95]

Federal Register Notice: FDAs Endocrinologic and Metabolic Drugs Advisory Committee will meet 10/18 to discuss Genyzme Corp.s NDA ...